Previous 10 | Next 10 |
The following slide deck was published by CONMED Corporation in conjunction with their 2022 Q2 earnings call. For further details see: CONMED Corporation 2022 Q2 - Results - Earnings Call Presentation
CONMED press release ( NYSE: CNMD ): Q2 Non-GAAP EPS of $0.76 beats by $0.01 . Revenue of $277.19M (+23.1% Y/Y) beats by $2.97M . The Company lowered its revenue guidance for the full year 2022 and now expects revenue between $1.095 billion and $1.140 billion c...
CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Highlights Sales of $277.2 million increased 8.6% year over year as reported and 9.8% in constant currency. Acquisitions contributed approx...
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2022 after the market close on Wednesday, July 27, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Conmed (NYSE:CNMD) completed the acquisition of the medical devices company In2Bones Global. The transaction is being financed through a combination of the net proceeds of CNMD's 2.25% convertible notes, borrowings under the company's amended and restated credit facility and cash on...
CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held In2Bones Global Inc. Headquartered in Memphis, Tennessee, In2Bones is a global developer, manufacturer, and distributor of medical devices for the treatme...
CONMED (NYSE:CNMD) priced its $700M principal amount of 2.25% convertible senior notes due 2027 in a private offering to qualified institutional buyers. It granted a 13-day option to initial purchasers an option to purchase up to an additional $100M principal amount of the notes. Offering is ...
CONMED Corporation (NYSE: CNMD) today announced the pricing of $700 million aggregate principal amount of 2.25% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “S...
CONMED Corporation (NYSE: CNMD) today announced that it intends to offer, subject to market conditions and other factors, $600 million aggregate principal amount of its convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A un...
News, Short Squeeze, Breakout and More Instantly...
Conmed Corp. - Ordinary Shares Company Name:
CNMD Stock Symbol:
NASDAQ Market:
Conmed Corp. - Ordinary Shares Website:
2024-07-18 18:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CONMED Corporation (NYSE: CNMD) today announced it will report financial results for the second quarter of 2024 after the market close on Wednesday, July 31, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participat...
2024-07-08 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...